Whole genome sequencing to decipher the virulence phenotype of hypervirulent Klebsiella pneumoniae responsible for liver abscess, Marseille, France.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
May 2021
Historique:
received: 18 08 2020
accepted: 21 10 2020
pubmed: 14 11 2020
medline: 21 8 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

We described three clinical cases of pyogenic liver abscess caused by hypervirulent Klebsiella pneumoniae (hvKp) successfully treated by prolonged antibiotherapy, in which one case was complicated by endophthalmitis. Whole genome sequencing helped to confirm the diagnosis of these hvKp strains, which belong to clonal complexes CC86 and CC23 and carried hvKp-associated genes (magA and/or rmpA). This syndrome is increasingly reported in France and Europe and raises questions about the source of infection.

Identifiants

pubmed: 33184752
doi: 10.1007/s10096-020-04080-7
pii: 10.1007/s10096-020-04080-7
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073-1077

Références

Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y (2012) Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 12:881–887. https://doi.org/10.1016/S1473-3099(12)70205-0
doi: 10.1016/S1473-3099(12)70205-0 pubmed: 23099082
Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard A-S et al (2014) Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis 20:1812–1820. https://doi.org/10.3201/eid2011.140206
doi: 10.3201/eid2011.140206 pubmed: 25341126 pmcid: 4214299
Luo Y, Wang Y, Ye L, Yang J (2014) Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 20:O818–O824. https://doi.org/10.1111/1469-0691.12664
doi: 10.1111/1469-0691.12664 pubmed: 24804560
MMC L, Wyres KL, Duchêne S, Wick RR, Judd LM, Gan Y-H et al (2018) Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat Commun 13(9):1–10. https://doi.org/10.1038/s41467-018-05114-7
doi: 10.1038/s41467-018-05114-7
Merlet A, Cazanave C, Dutronc H, de Barbeyrac B, Brisse S, Dupon M (2012) Primary liver abscess due to CC23-K1 virulent clone of Klebsiella pneumoniae in France. Clin Microbiol Infect 18:E338–E339. https://doi.org/10.1111/j.1469-0691.2012.03953.x
doi: 10.1111/j.1469-0691.2012.03953.x pubmed: 22757694
Lan P, Shi Q, Zhang P, Chen Y, Yan R, Hua X et al (2020) Core genome allelic profiles of clinical Klebsiella pneumoniae strains using a random forest algorithm based on multilocus sequence typing scheme for hypervirulence analysis. J Infect Dis 16(221):S263–S271. https://doi.org/10.1093/infdis/jiz562
doi: 10.1093/infdis/jiz562
Baron SA, Cassir N, Mékidèche T, Mlaga KD, Brouqui P, Rolain J-M (2019) Successful treatment and digestive decolonisation of a patient with osteitis caused by a carbapenemase-producing Klebsiella pneumoniae isolate harbouring both NDM-1 and OXA-48 enzymes. J Glob Antimicrob Resist 18:225–229. https://doi.org/10.1016/j.jgar.2019.06.001
doi: 10.1016/j.jgar.2019.06.001 pubmed: 31201994
Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G et al (2018) Hypervirulent Klebsiella pneumoniae in cryptogenic liver abscesses, Paris. France Emerging Infect Dis 24:221–229. https://doi.org/10.3201/eid2402.170957
doi: 10.3201/eid2402.170957
Surgers L, Boyd A, Girard P-M, Arlet G, Decré D (2016) ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France. Emerg Infect Dis 22:1687–1688. https://doi.org/10.3201/eid2209.160681
doi: 10.3201/eid2209.160681 pubmed: 27532217 pmcid: 4994372
Rafat C, Messika J, Barnaud G, Dufour N, Magdoud F, Billard-Pomarès T et al (2018) Hypervirulent Klebsiella pneumoniae, a 5-year study in a French ICU. J Med Microbiol 67:1083–1089. https://doi.org/10.1099/jmm.0.000788
doi: 10.1099/jmm.0.000788 pubmed: 29972348
Choby JE, Howard-Anderson J, Weiss DS (2020) Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives. J Intern Med 287:283–300. https://doi.org/10.1111/joim.13007
doi: 10.1111/joim.13007 pubmed: 31677303
Pinpimai K, Roe WD, Biggs PJ, Dittmer KE, Michael SA (2018) Draft whole-genome sequences of five Klebsiella pneumoniae isolates from the Subantarctic Islands of New Zealand. Microbiol Resour Announc 7. https://doi.org/10.1128/MRA.01328-18
Anzai EK, de Souza Júnior JC, Peruchi AR, Fonseca JM, Gumpl EK, Pignatari ACC et al (2017) First case report of non-human primates (Alouatta clamitans) with the hypervirulent Klebsiella pneumoniae serotype K1 strain ST 23: a possible emerging wildlife pathogen. J Med Primatol 46:337–342. https://doi.org/10.1111/jmp.12296
doi: 10.1111/jmp.12296 pubmed: 28809435
Harada S, Doi Y (2018) Hypervirulent Klebsiella pneumoniae: a call for Consensus Definition and International Collaboration. J Clin Microbiol 56. https://doi.org/10.1128/JCM.00959-18
Beyrouthy R, Dalmasso G, Birer A, Robin F, Bonnet R (2020) Carbapenem resistance conferred by OXA-48 in K2-ST86 hypervirulent Klebsiella pneumoniae. France Emerging Infect Dis 26:1529–1533. https://doi.org/10.3201/eid2607.191490
doi: 10.3201/eid2607.191490
Du P, Zhang Y, Chen C (2018) Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect Dis 18:23–24. https://doi.org/10.1016/S1473-3099(17)30625-4
doi: 10.1016/S1473-3099(17)30625-4 pubmed: 29102520

Auteurs

Sophie Alexandra Baron (SA)

IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.
IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.

Léa-Marie Pascale (LM)

IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.
IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.

Matthieu Million (M)

IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.
IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.

Antoine Briantais (A)

Service de Médecine Interne, Hôpital La Timone, APHM, Marseille, France.

Jean-Marc Durand (JM)

Service de Médecine Interne, Hôpital La Timone, APHM, Marseille, France.

Linda Hadjadj (L)

IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.
IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France.

Jean-Marc Rolain (JM)

IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France. jean-marc.rolain@univ-amu.fr.
IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France. jean-marc.rolain@univ-amu.fr.
IRD, APHM, MEPHI, IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Aix Marseille Univ, 19-21 boulevard Jean Moulin, 13385, Marseille, CEDEX 05, France. jean-marc.rolain@univ-amu.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH